TrialInflammopharmacology2019

International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.

Zahra Rezaieyazdi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.